Advisory Committee to the Director, Centers for Disease Control and Prevention, 1583-1584 [2023-00408]
Download as PDF
<![CDATA[
Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
The meeting will be held on
February 15, 2023, from 11:00 a.m. to
4:30 p.m., EST.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Instructions to access the
live meeting broadcast will be posted
here: https://www.cdc.gov/nchs/about/
bsc/bsc_meetings.htm.
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Notice of Closed Meeting
[Docket No. CDC–2023–0001]
Rebecca Hines, M.H.S., Designated
Federal Officer, Board of Scientific
Counselors, National Center for Health
Statistics, Centers for Disease Control
and Prevention, 3311 Toledo Road,
Mailstop P–08, Hyattsville, Maryland
20782; Telephone (301) 458–4715;
Email: RSHines@cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Board of Scientific
Counselors, National Center for Health
Statistics (BSC, NCHS) is charged with
providing advice and making
recommendations to the Secretary,
Department of Health and Human
Services; the Director, Centers for
Disease Control and Prevention (CDC);
and the Director, National Center for
Health Statistics, regarding the scientific
and technical program goals and
objectives, strategies, and priorities of
NCHS.
Matters to be Considered: The
meeting agenda will include a Center
update from the NCHS Director; an
update on CDC’s Data Modernization
Initiative; program updates from NCHS
Division Directors; and time for Board
discussion regarding current issues and
topics. The Board will reserve time for
public comment at the end of the day.
Meeting times and agenda topics are
subject to change as priorities dictate.
Meeting Information: Please visit the
BSC, NCHS website for details: https://
www.cdc.gov/nchs/about/bsc/bsc_
meetings.htm. Further information and
the meeting agenda will be available on
the BSC website, including any agenda
updates and the instructions for
accessing the live meeting broadcast.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–CE23–003: Grants to Support New
Investigators in Conducting Research
Related to Preventing Interpersonal
Violence Impacting Children and Youth.
Date: February 28–March 1, 2023.
Time: 8:30 a.m.–5:30 p.m., EST.
Place: Videoconference.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Carlisha Gentles, PharmD, BCPS,
CDCES, Scientific Review Officer,
National Center for Injury Prevention
and Control, CDC, 4770 Buford Highway
NE, Mailstop F–63, Atlanta, Georgia
30341, Telephone: (770) 488–1504,
Email: CGentles@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Advisory Committee to the Director,
Centers for Disease Control and
Prevention
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–00407 Filed 1–10–23; 8:45 am]
[FR Doc. 2023–00241 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–19–P
BILLING CODE 4163–18–P
DATES:
ADDRESSES:
FOR FURTHER INFORMATION CONTACT:
lotter on DSK11XQN23PROD with NOTICES1
1583
VerDate Sep<11>2014
17:17 Jan 10, 2023
Jkt 259001
PO 00000
Frm 00028
Fmt 4703
Sfmt 4703
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting and request
for comment.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Advisory Committee to the
Director, Centers for Disease Control
and Prevention (ACD, CDC). This
meeting is open to the public. The
meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on
February 7, 2023, from 10 a.m. to 3:30
p.m., EST (times subject to change). The
public may submit written comments on
or before January 27, 2023.
ADDRESSES: Information for accessing
the webcast will be available at https://
www.cdc.gov/about/advisorycommittee-director/.
Written comments: You may submit
comments, identified by Docket No.
CDC–2023–0001, by any of the
following methods. Do not submit
comments for the docket by email. CDC
does not accept comments for the
docket by email.
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
• Mail: Kerry Caudwell, DPA, Centers
for Disease Control and Prevention,
1600 Clifton Road NE, MS H21–10,
Atlanta, Georgia 30329–4027. Attn:
Docket number CDC–2023–0001.
Instructions: All submissions received
must include the Agency name and
Docket Number. All relevant comments
received in conformance with the
https://www.regulations.gov suitability
policy will be posted without change to
https://www.regulations.gov, including
any personal information provided. For
access to the docket to read background
documents or comments received, go to
https://www.regulations.gov. Written
public comments submitted up to 72
hours prior to the ACD meeting will be
provided to ACD members before the
meeting. Written comments received in
advance of the meeting will be included
in the official record of the meeting.
FOR FURTHER INFORMATION CONTACT:
Kerry Caudwell, DPA, Office of the
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
1584
Federal Register / Vol. 88, No. 7 / Wednesday, January 11, 2023 / Notices
Chief of Staff, Centers for Disease
Control and Prevention, 1600 Clifton
Road NE, MS H21–10, Atlanta, Georgia
30329–4027, Telephone: (404) 639–
0390; Email Address: ACDirector@
cdc.gov.
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to
the Director (ACD), CDC, shall advise
the Secretary, HHS, and the Director,
CDC, on policy and broad strategies that
will enable CDC to fulfill its mission of
protecting health through health
promotion, prevention, and
preparedness. The committee
recommends ways to prioritize CDC’s
activities, improve results, and address
health disparities. It also provides
guidance to help CDC work more
effectively with its various private and
public sector constituents to make
health protection a practical reality.
Matters To Be Considered: The
agenda will include discussions on
CDC’s current work and priorities as
they relate to health equity and data and
surveillance recommendations to the
Department of Health and Human
Services and CDC Director. The agenda
also includes a laboratory workgroup
update with recommended action steps
to the full ACD Committee, along with
an update on the public health
infrastructure grant. Agenda items are
subject to change as priorities dictate.
lotter on DSK11XQN23PROD with NOTICES1
Public Participation
Interested persons or organizations
are invited to participate by submitting
written views, recommendations, and
data. Please note that comments
received, including attachments and
other supporting materials, are part of
the public record and are subject to
public disclosure. Comments will be
posted on https://www.regulations.gov.
Therefore, do not include any
information in your comment or
supporting materials that you consider
confidential or inappropriate for public
disclosure. If you include your name,
contact information, or other
information that identifies you in the
body of your comments, that
information will be on public display.
CDC will review all submissions and
may choose to redact, or withhold,
submissions containing private or
proprietary information such as Social
Security numbers, medical information,
inappropriate language, or duplicate/
near duplicate examples of a mass-mail
campaign. CDC will carefully consider
all comments submitted into the docket.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
VerDate Sep<11>2014
17:17 Jan 10, 2023
Jkt 259001
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–00408 Filed 1–10–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
BILLING CODE 4163–18–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended, and the Determination of
the Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, CDC, pursuant to
Public Law 92–463. The grant
applications and the discussions could
disclose confidential trade secrets or
commercial property such as patentable
material, and personal information
concerning individuals associated with
the grant applications, the disclosure of
which would constitute a clearly
unwarranted invasion of personal
privacy.
Name of Committee: Disease,
Disability, and Injury Prevention and
Control Special Emphasis Panel (SEP)—
RFA–IP–23–001, Public Health
Epidemiology, Prevention and Control
of Influenza and Other Respiratory
Pathogens in China, RFA–IP–23–004,
Developing, Implementing, and
Evaluating Protocols to Increase Routine
Adult Immunization Coverage Among
Persons Who are Incarcerated, and
RFA–IP–23–005, Approach to Adult
Vaccine Counseling.
Date: April 11–12, 2023.
Time: 10 a.m.–5 p.m., EDT.
Place: Teleconference, Centers for
Disease Control and Prevention, Room
1077, 8 Corporate Boulevard, Atlanta,
Georgia 30329.
Agenda: To review and evaluate grant
applications.
For Further Information Contact:
Gregory Anderson, M.S., M.P.H.,
Scientific Review Officer, National
Frm 00029
Fmt 4703
Sfmt 4703
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2023–00242 Filed 1–10–23; 8:45 am]
Notice of Closed Meeting
PO 00000
Center for HIV, Viral Hepatitis, STD,
and TB Prevention, CDC, 1600 Clifton
Road NE, Mailstop US8–1, Atlanta,
Georgia 30329–4027; Telephone: (404)
718–8833; Email: GAnderson@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency for Toxic Substances and
Disease Registry
[60Day–23–0063; Docket No. ATSDR–2022–
0007]
Proposed Data Collection Submitted
for Public Comment and
Recommendations
Agency for Toxic Substances
and Disease Registry (ATSDR),
Department of Health and Human
Services (HHS).
ACTION: Notice with comment period.
AGENCY:
The Agency for Toxic
Substances and Disease Registry
(ATSDR), as part of its continuing effort
to reduce public burden and maximize
the utility of government information,
invites the general public and other
federal agencies the opportunity to
comment on a continuing information
collection, as required by the Paperwork
Reduction Act of 1995. This notice
invites comment on a proposed
information collection project titled
Human Health Effects of Drinking Water
Exposures to Per- and Polyfluoroalkyl
Substances (PFAS): A Multi-site Crosssectional Study (The Multi-site Study).
The purpose of this research is to use
sound study methods to see if drinking
water exposure to PFAS is related to
health outcomes.
DATES: ATSDR must receive written
comments on or before March 13, 2023.
ADDRESSES: You may submit comments,
identified by Docket No. ATSDR–2022–
0007 by either of the following methods:
SUMMARY:
E:\FR\FM\11JAN1.SGM
11JAN1
]]>Agencies
[Federal Register Volume 88, Number 7 (Wednesday, January 11, 2023)]
[Notices]
[Pages 1583-1584]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-00408]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2023-0001]
Advisory Committee to the Director, Centers for Disease Control
and Prevention
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting and request for comment.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Advisory Committee to the
Director, Centers for Disease Control and Prevention (ACD, CDC). This
meeting is open to the public. The meeting will be webcast live via the
World Wide Web.
DATES: The meeting will be held on February 7, 2023, from 10 a.m. to
3:30 p.m., EST (times subject to change). The public may submit written
comments on or before January 27, 2023.
ADDRESSES: Information for accessing the webcast will be available at
https://www.cdc.gov/about/advisory-committee-director/.
Written comments: You may submit comments, identified by Docket No.
CDC-2023-0001, by any of the following methods. Do not submit comments
for the docket by email. CDC does not accept comments for the docket by
email.
Federal eRulemaking Portal: https://www.regulations.gov.
Follow the instructions for submitting comments.
Mail: Kerry Caudwell, DPA, Centers for Disease Control and
Prevention, 1600 Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-
4027. Attn: Docket number CDC-2023-0001.
Instructions: All submissions received must include the Agency name
and Docket Number. All relevant comments received in conformance with
the https://www.regulations.gov suitability policy will be posted
without change to https://www.regulations.gov, including any personal
information provided. For access to the docket to read background
documents or comments received, go to https://www.regulations.gov.
Written public comments submitted up to 72 hours prior to the ACD
meeting will be provided to ACD members before the meeting. Written
comments received in advance of the meeting will be included in the
official record of the meeting.
FOR FURTHER INFORMATION CONTACT: Kerry Caudwell, DPA, Office of the
[[Page 1584]]
Chief of Staff, Centers for Disease Control and Prevention, 1600
Clifton Road NE, MS H21-10, Atlanta, Georgia 30329-4027, Telephone:
(404) 639-0390; Email Address: [email protected].
SUPPLEMENTARY INFORMATION:
Purpose: The Advisory Committee to the Director (ACD), CDC, shall
advise the Secretary, HHS, and the Director, CDC, on policy and broad
strategies that will enable CDC to fulfill its mission of protecting
health through health promotion, prevention, and preparedness. The
committee recommends ways to prioritize CDC's activities, improve
results, and address health disparities. It also provides guidance to
help CDC work more effectively with its various private and public
sector constituents to make health protection a practical reality.
Matters To Be Considered: The agenda will include discussions on
CDC's current work and priorities as they relate to health equity and
data and surveillance recommendations to the Department of Health and
Human Services and CDC Director. The agenda also includes a laboratory
workgroup update with recommended action steps to the full ACD
Committee, along with an update on the public health infrastructure
grant. Agenda items are subject to change as priorities dictate.
Public Participation
Interested persons or organizations are invited to participate by
submitting written views, recommendations, and data. Please note that
comments received, including attachments and other supporting
materials, are part of the public record and are subject to public
disclosure. Comments will be posted on https://www.regulations.gov.
Therefore, do not include any information in your comment or supporting
materials that you consider confidential or inappropriate for public
disclosure. If you include your name, contact information, or other
information that identifies you in the body of your comments, that
information will be on public display. CDC will review all submissions
and may choose to redact, or withhold, submissions containing private
or proprietary information such as Social Security numbers, medical
information, inappropriate language, or duplicate/near duplicate
examples of a mass-mail campaign. CDC will carefully consider all
comments submitted into the docket.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2023-00408 Filed 1-10-23; 8:45 am]
BILLING CODE 4163-18-P
